4
Changes in Ownership
Edgewise Therapeutics, Inc. Filed Acc 0001562180-22-005386
Options or other derivatives
- Director acquired 42,087 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Thompson Peter A. · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-06-24 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +42,087 | 42,087 | D |
Loading xslF345X03/primarydocument.xml…